Offer - Urjas Oil for just ₹ 1 X
Lamihope is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Hepatitis B. The alternative uses of Lamihope have also been explained below.
The optimal dosage of Lamihope is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Lamihope can also lead to other problems, which have been listed below. Usually, these side effects of Lamihope go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Lamihope's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Lamihope's effects on the liver, heart and kidney are discussed below in the Lamihope related warnings section.
Lamihope can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lamihope in conditions like Kidney Disease, Pancreatitis. Other contraindications of Lamihope have been discussed in the sections ahead.
Besides this, Lamihope may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Lamihope is safe while driving, and is is addictive in nature.
Lamihope is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lamihope safe for pregnant women?
Lamihope may have some side effects during pregnancy. Pregnant women should discontinue the use of Lamihope, and talk to their doctor, if they notice any discomfort.
Is the use of Lamihope safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Lamihope. Immediately discontinue Lamihope if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Lamihope on the Kidneys?
Lamihope may have mild side effects on the kidneys.
What is the effect of Lamihope on the Liver?
Side effects of Lamihope rarely affect the liver.
What is the effect of Lamihope on the Heart?
You can take Lamihope without any fear of damage to the heart.
Lamihope should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lamihope unless your doctor advises you to do so -
Is this Lamihope habit forming or addictive?
Forming a habit of Lamihope has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Lamihope since it does not cause drowsiness.
Is it safe?
Yes, but consume Lamihope only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Lamihope in mental disorders is not effective.
Interaction between Food and Lamihope
Taking Lamihope with food does not harm your health.
Interaction between Alcohol and Lamihope
Consumption of alcohol and Lamihope together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99